“Prediction of Toxicities Induced by Sorafenib and Regorafenib”. Precision Medicine Communications 2, no. 2 (December 31, 2022): 85–89. Accessed May 8, 2026. https://rootspress.org/journals/index.php/PMC/article/view/171.